Risk Factors for Poor Adherence to Betaferon^® Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome

• Łukasz Jernas,

  Affiliation Department of Neurology, Poznań University of Medical Sciences, Poznań, Poland

  ⨯
• Jacek Wencel,

  Affiliation Department of Neurolofy, "L. Bierkowski" Ministry of Internal Affairs and Administration Health Care Centre in Poznan, Poznań, Poland

  ⨯
• Andrzej Wiak,

  Affiliation Department of Neurology, 4th Military Clinical Hospital in Wrocław, Wrocław, Poland

  ⨯
• Marek Bieniek ,

  * E-mail: marek.bieniek@bayer.com

  Affiliation Bayer Sp. z o.o, Pharmaceuticals, Medical Department, Warsaw, Poland

  ⨯
• Halina Bartosik-Psujek

  Affiliation Faculty of Medicine. University of Rzeszow, Rzeszów, Poland

  ⨯